New Key Statistics Module, Z-Score and F-Score
NYSE:ADCT Key Ratios
| Market Cap $ M | 141.71 |
| Enterprise Value $ M | 40.16 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 2.09 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 79.00 |
| EPS (TTM) $ | -0.66 |
| Beneish M-Score | 2.94 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 27.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.89 |
| EV-to-EBITDA | -0.90 |
| PEG | -- |
| Shares Outstanding M | 127.67 |
| Net Margin (%) | -121.77 |
| Operating Margin % | -121.22 |
| Pre-tax Margin (%) | -122.28 |
| Quick Ratio | 2.97 |
| Current Ratio | 3.03 |
| ROA % (ttm) | -32.19 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -247.79 |
| Dividend Yield % | -- |
| Altman Z-Score | -7.78 |
ADCT Number of Guru Trades
ADCT Volume of Guru Trades
Gurus Latest Trades with NYSE:ADCT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:ADCT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ADC Therapeutics SA Insider Transactions
No Available Data
News about NYSE:ADCT
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers